Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 60,636 shares of the company's stock, valued at approximately $1,838,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.07% of Acadia Healthcare at the end of the most recent quarter.
Several other large investors have also bought and sold shares of ACHC. UMB Bank n.a. lifted its stake in Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after acquiring an additional 755 shares in the last quarter. Quadrant Capital Group LLC lifted its stake in Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after acquiring an additional 933 shares in the last quarter. State of Wyoming bought a new position in Acadia Healthcare during the 4th quarter valued at $56,000. Covestor Ltd lifted its stake in Acadia Healthcare by 27.2% during the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after acquiring an additional 310 shares in the last quarter. Finally, Aquatic Capital Management LLC bought a new position in Acadia Healthcare during the 4th quarter valued at $97,000.
Analyst Ratings Changes
Several equities analysts have weighed in on the company. Stephens upgraded Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Barclays decreased their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Guggenheim started coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 target price for the company. Mizuho decreased their price objective on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th. Finally, KeyCorp decreased their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $47.94.
Get Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Price Performance
ACHC stock traded down $0.68 during mid-day trading on Friday, reaching $21.09. 1,874,471 shares of the company traded hands, compared to its average volume of 2,140,247. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35. The company has a market capitalization of $1.94 billion, a P/E ratio of 10.39, a P/E/G ratio of 4.28 and a beta of 0.93. Acadia Healthcare Company, Inc. has a 52-week low of $20.35 and a 52-week high of $82.40. The company has a fifty day moving average price of $22.52 and a 200-day moving average price of $28.85.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The company's revenue for the quarter was up .3% on a year-over-year basis. During the same quarter last year, the company posted $0.84 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.